Bergamot vs berberine: which one do you need?

Your LDL came back high. Maybe your fasting glucose is creeping up. You've heard berberine is like metformin without the prescription, and you've heard bergamot can do what statins do without the muscle pain. So you start researching, and now you're confused. They both lower cholesterol. They both improve blood sugar. They're both natural. So what's the difference, and which one do you actually need?

The answer depends entirely on what's driving your problem.

Bergamot and berberine are not the same compound doing the same thing. Their mechanisms are completely different, their evidence profiles point in different directions, and their ideal use cases don't fully overlap. Bergamot is, mechanistically speaking, a natural statin. Berberine is, mechanistically speaking, a natural metformin. That distinction changes everything about how you choose between them, how you dose them, and whether you should stack them.

This guide breaks down both compounds from the ground up: how each works, what the clinical evidence actually shows, who benefits most from each, and how the combination performs when you need both angles covered. By the end, you'll have a clear answer for your specific situation.

What bergamot extract actually is

First, an important clarification. Bergamot the supplement is not the same as bergamot essential oil. It's not what flavors your Earl Grey tea. The supplement form uses a standardized polyphenolic extract from the juice of Citrus bergamia, a citrus fruit grown almost exclusively in the Calabria region of southern Italy. Same fruit, very different product, and confusing these two leads to real errors in both expectations and safety considerations.

The fruit juice extract contains five dominant polyphenols that account for more than 95% of its active content. Neoeriocitrin, naringenin, neohesperidin, and two compounds unique to bergamot called brutieridin and melitidin. Those last two are the ones that make bergamot genuinely interesting from a cardiovascular standpoint.

The statin-like mechanism

Brutieridin and melitidin contain an HMG moiety attached to glucose in a way that allows them to fit directly into the catalytic pocket of HMG-CoA reductase, the enzyme that controls cholesterol synthesis in the liver. Statins work by blocking this exact same enzyme. This isn't a coincidence or a loose analogy. Molecular modeling has confirmed the structural fit. This is why bergamot is sometimes called a "natural statin," and why, unlike most supplements in that category, the label actually holds up to scrutiny.

But bergamot doesn't stop there. The other polyphenols activate AMPK (the same metabolic master switch berberine targets, though through a different upstream pathway), reduce intestinal cholesterol absorption through pancreatic cholesterol ester hydrolase inhibition, upregulate LDL receptors on liver cells, and reduce LDL oxidation by suppressing LOX-1 receptor expression. LOX-1 is the receptor that allows oxidized LDL to enter artery walls and form plaques. Reducing it matters as much as reducing LDL quantity, maybe more.

What this creates is a multi-pronged cardiovascular intervention. Bergamot doesn't just lower the number on your cholesterol panel. It reduces cholesterol synthesis, improves clearance, decreases absorption, and makes the LDL that remains in circulation less likely to damage your arteries. That combination is what separates it from most supplements that claim cardiovascular benefits without the mechanism to back it up.

What the clinical trials show

The landmark bergamot trial came from Mollace and colleagues in 2011. Two hundred and thirty-seven participants with combined hyperlipidemia were randomized to 500 mg per day of bergamot polyphenol fraction, 1,000 mg per day, or placebo for 30 days.

At 500 mg per day, total cholesterol dropped 21.8%. LDL fell 24.1%, going from 175 to 116 mg/dL. Triglycerides came down 30.5%. HDL rose 25.9%. And fasting glucose fell from 120 to 98 mg/dL. These aren't modest effects. A 24% reduction in LDL over 30 days from a natural compound is remarkable. For context, a low-dose statin typically produces 20-35% LDL reduction.

A 2015 trial by Toth and colleagues enrolled 80 subjects and specifically looked at carotid intima-media thickness, a direct measure of arterial plaque burden. After six months of bergamot polyphenols, carotid plaque thickness fell from 1.2 to 0.9 mm, a 25% reduction. More importantly, bergamot reduced small dense LDL particles specifically. Small dense LDL is the most atherogenic fraction, the tiny particles that slip through artery walls most easily. Standard cholesterol panels don't even measure this. Bergamot improves the one metric that might matter more than total LDL, and does it in a way most interventions don't.

A systematic review published in Critical Reviews in Food Science and Nutrition (Whittaker & Dew, 2019) reviewed all human trials and found consistent LDL reductions of 7.6% to 40.8% across studies, with most falling in the 20-30% range at 500-1,000 mg per day. The International Lipid Expert Panel has given bergamot a Class IIa recommendation with Level B evidence, putting it in the same category as red yeast rice, plant sterols, and other evidence-based natural cholesterol interventions.

For blood sugar specifically, bergamot has real but secondary effects. The Mollace trial showed an 18.9% fasting glucose reduction at 500 mg per day. More recent RCTs have confirmed improvements in HOMA-IR (an insulin resistance marker) and modest glycemic improvements in overweight and obese subjects. But blood sugar is not bergamot's primary strength. That belongs to berberine.

What berberine actually does

Berberine is an isoquinoline alkaloid extracted from the roots of plants like Berberis vulgaris (barberry), goldenseal, and Chinese goldthread. It's been used in traditional Chinese and Ayurvedic medicine for thousands of years. What modern pharmacology has uncovered about its mechanisms explains why it's earned genuine respect in metabolic medicine.

The metformin-like mechanism

Berberine's primary effect is activating AMPK by inhibiting mitochondrial respiratory complex I. When complex I is mildly inhibited, the AMP-to-ATP ratio in cells rises, and AMPK switches on. This is almost identical to metformin's primary mechanism. AMPK activation then triggers a cascade: cells take up more glucose from the bloodstream, the liver slows its production of new glucose through gluconeogenesis, fat burning increases, and lipid metabolism shifts in ways that lower LDL and triglycerides.

But berberine doesn't stop at AMPK. It also inhibits PCSK9, a protein that degrades LDL receptors on liver cells. Less PCSK9 means more LDL receptors. More LDL receptors means more LDL gets cleared from circulation. PCSK9 inhibition is, incidentally, the mechanism targeted by some of the most expensive cholesterol drugs ever developed (evolocumab, alirocumab). Berberine does something similar through a different pathway. And berberine stimulates gut L-cells to release GLP-1, the hormone targeted by semaglutide (Ozempic), contributing to blood sugar regulation and appetite effects.

Because berberine is poorly absorbed (roughly 5% bioavailability for standard HCl), most of it acts directly in the gut. It remodels the gut microbiome, increasing Akkermansia muciniphila and Lactobacillus species, both associated with metabolic health and longevity. This gut axis effect is something bergamot simply doesn't have.

What the clinical trials show

The most cited berberine trial compared it directly to metformin. Zhang and colleagues (2008) randomized patients with type 2 diabetes to berberine 500 mg three times daily or metformin at the same frequency. After 12 weeks, fasting glucose fell 12.6 mg/dL with berberine versus 10.8 mg/dL with metformin. Postprandial glucose dropped more with berberine. HbA1c fell -0.31% with berberine versus -0.28% with metformin. Berberine was slightly more effective than metformin in this direct comparison. That's not a small finding. That's a prescription drug being matched by a plant alkaloid.

A 2025 meta-analysis pooling 32 randomized controlled trials with over 2,800 participants found that berberine reduced fasting blood glucose by an average of 20 mg/dL and HbA1c by 0.7% compared to placebo. One individual trial in severely uncontrolled type 2 diabetics (Yin et al., 2008) found HbA1c falling from 9.5% to 7.5% in three months, a 2.0 percentage point drop that would represent meaningful clinical improvement.

For cholesterol, berberine is effective but not as dramatic as bergamot. A 2023 meta-analysis pooling 41 RCTs found berberine reduced LDL by roughly 14-18 mg/dL on average, compared to bergamot's 20-40 mg/dL in head-to-head studies. Berberine's triglyceride reductions are comparable to bergamot's. HDL improvement is modest for both.

The heart failure data for berberine is one of its most compelling underappreciated findings. A randomized trial in patients with congestive heart failure found that berberine increased ejection fraction, reduced dangerous arrhythmias, and at follow-up, seven patients died in the berberine group versus 13 in the placebo group. It's a relatively small study but the signal is striking.

Use WinAging's supplement interaction checker before adding berberine to your stack, especially if you're on any medications. The interaction profile matters here.

The fundamental difference

Here's the cleanest way to think about this: bergamot works like a statin, berberine works like metformin.

Statins and metformin both address cardiovascular risk, but they hit completely different targets. Statins are primarily cholesterol drugs. Metformin is primarily a glucose and insulin drug. Statins rarely produce dramatic blood sugar improvements. Metformin rarely produces dramatic LDL-C reductions. The two drugs are often prescribed together in metabolic syndrome precisely because they're complementary, not redundant.

Bergamot and berberine follow the same logic. Bergamot's strongest evidence is in lipid panels, cardiovascular markers, and arterial plaque. Berberine's strongest evidence is in blood sugar control, insulin resistance, and metabolic syndrome. If your primary problem is cholesterol, bergamot is the more targeted choice. If your primary problem is blood sugar and insulin resistance, berberine is the more targeted choice. If you have metabolic syndrome, with both lipid dysregulation and insulin resistance, the combination addresses the full picture.

	Bergamot	Berberine
Primary mechanism	HMG-CoA reductase inhibition (statin-like)	AMPK activation (metformin-like)
Cholesterol (LDL) effect	-20 to -40%	-10 to -18%
Triglycerides	-30%	-18 mg/dL avg
Blood sugar (fasting)	-10 to -22%	-20 mg/dL avg
HbA1c	Not well studied	-0.7% avg vs placebo
Carotid plaque	Reduced (Toth 2015)	Not studied
Gut microbiome	Prebiotic effect	Direct remodeling
NAFLD/liver	Limited data	Strong evidence
Bioavailability	Well-absorbed polyphenols	~5% (HCl form)

Who should use bergamot

Bergamot is the better first choice when elevated cholesterol is the primary concern and blood sugar is relatively well controlled.

People with LDL above 130 mg/dL who want to avoid or reduce statins are the ideal candidates. The clinical data shows LDL reductions in the 20-40% range, which is enough to meaningfully move most people's numbers. The small dense LDL data is particularly relevant here. If you've had an advanced lipid panel showing elevated sdLDL or ApoB particles, bergamot specifically reduces this atherogenic fraction in a way most interventions don't.

People who are statin-intolerant find bergamot especially relevant. Statin myopathy (muscle pain) leads a meaningful percentage of statin users to stop their medication. Bergamot operates through a different mechanism than a statin, which doesn't entirely eliminate the risk of statin side effects if you're stacking them, but people who react poorly to statins often find they can use bergamot without the same muscle symptoms. The mechanism is similar but the molecular structure is different enough that cross-reactivity isn't automatic.

People already on low-dose statins who want to enhance the effect without raising the dose are another natural fit. Bergamot adds statin-like mechanism through a complementary pathway, and the combination of bergamot plus low-dose statin has produced greater LDL reductions than either alone in clinical settings.

And people concerned about cardiovascular risk beyond just LDL numbers should pay particular attention to bergamot's effects on carotid plaque, oxidized LDL, and LOX-1 expression. These markers are arguably more predictive of actual atherosclerosis risk than total LDL, and bergamot's effect on them is unusual for a natural compound.

WinAging tracks this research in depth, including the clinical evidence for each cardiovascular compound and how they compare against pharmaceutical alternatives.

Who should use berberine

Berberine is the better first choice when insulin resistance, blood sugar control, or metabolic syndrome are the primary concerns.

Prediabetes is probably the highest-value use case for berberine. HbA1c between 5.7% and 6.4%, fasting glucose above 100, rising over years despite reasonable lifestyle. Berberine's ability to match metformin's HbA1c-lowering effect puts it in a class by itself among natural compounds. For people who don't want to start a prescription drug for a borderline condition, berberine is the most evidence-backed alternative.

People with full type 2 diabetes already on medication need medical supervision before adding berberine, because the combined blood sugar-lowering effect can cause hypoglycemia. But for newly diagnosed patients or those at the early end of the disease, berberine as a standalone or adjunct intervention has substantial clinical support.

Insulin resistance without a diabetes diagnosis is extremely common and often not treated aggressively until it progresses further. High fasting insulin, high HOMA-IR, post-meal blood sugar spikes, difficulty losing weight despite reasonable calorie control. Berberine addresses the core mechanism here in a way that nothing else in the natural supplement world matches.

NAFLD (non-alcoholic fatty liver disease) is another strong indication for berberine. The compound reduces hepatic fat content, lowers liver enzymes, modulates the gut-liver axis through microbiome effects, and reduces the fibrosis markers associated with liver disease progression. For people with elevated ALT or AST on bloodwork, berberine is worth discussing with a physician.

The longevity angle on berberine is specifically about AMPK activation. AMPK is one of the key pathways targeted by caloric restriction and intermittent fasting. It drives mitophagy, stimulates SIRT1, and shifts cells toward maintenance and repair over growth. Berberine activates this pathway pharmacologically. This is why longevity researchers like Peter Attia have discussed berberine as relevant for metabolic health optimization, particularly for people with insulin resistance or those who want to mimic some effects of caloric restriction without actually restricting calories.

Not sure how to build a stack around berberine for your specific goals? The AI protocol builder creates a personalized longevity protocol based on your age, goals, and biomarkers. It takes about 10 minutes.

Stacking bergamot and berberine

Here's where the combination gets genuinely interesting.

The two compounds hit different targets in the cholesterol pathway. Bergamot blocks synthesis through HMG-CoA reductase inhibition. Berberine reduces clearance impairment through PCSK9 inhibition and LDL receptor upregulation. These mechanisms are complementary, not redundant. Using both simultaneously means you're reducing how much cholesterol the liver makes while also increasing how efficiently the liver removes cholesterol from circulation.

The clinical evidence for the combination exists. A study using combined bergamot, berberine, soy, and phytosterols alongside a Mediterranean diet achieved 37% LDL-C reduction and 50.8% triglyceride reduction. Those are the kinds of numbers that compete with pharmaceutical intervention. A published product called Recapsoma, combining bergamot and liposomal berberine with policosanol, showed significant lipid improvements in clinical testing (published in PMC, 2022). No known pharmacokinetic interactions exist between bergamot polyphenols and berberine.

The metabolic syndrome use case is the clearest argument for the combination. If you have elevated LDL, elevated fasting glucose, elevated triglycerides, and low HDL simultaneously, you have both the lipid problem that bergamot addresses and the insulin resistance problem that berberine addresses. Neither compound alone covers the full picture. Together, they do.

Practical stacking dosage: bergamot at 500-1,000 mg per day and berberine at 500 mg two to three times daily (or 200-400 mg phytosome form). The two don't need to be taken at the same time, though taking them with the same meals is convenient. Check interactions with any current medications using the supplement interaction checker before starting both.

Dosage guide

Bergamot dosage

The standard effective dose is 500 mg per day of standardized extract. The Mollace 2011 trial used this dose and produced dramatic results within 30 days. The 1,000 mg dose produces somewhat greater HDL improvements. Most people don't need to go above 1,000 mg daily. The dose range studied in clinical trials runs from 200 to 1,500 mg per day, with the 500-1,000 mg range showing the most consistent benefit.

Take bergamot before or with meals. Benefits appear within 30 days and are sustained with continued use. Look specifically for products using "Bergamonte" branded extract, standardized to 38% total polyphenols. This is the extract used in most published trials. Generic bergamot extracts standardized to minimum 25-38% polyphenols are the alternative.

A critical note on forms: bergamot essential oil is not the same product. It's used in aromatherapy and food flavoring. The metabolic and cardiovascular benefits described in this article come specifically from standardized juice extract. If a product doesn't specify polyphenol content from the juice extract, it's not what the research supports.

Berberine dosage

Standard berberine dosing is 500 mg taken two to three times daily with meals, totaling 1,000-1,500 mg per day. Dividing doses keeps blood levels more stable throughout the day and reduces GI side effects compared to a single large dose. The research supporting berberine as a metformin equivalent uses three times daily dosing.

Start at the lower end. Begin with 500 mg once daily with your largest meal for the first two weeks. Your gut microbiome will be shifting, and GI effects (bloating, loose stools, cramping) are more common in the first few weeks. Titrating up reduces the severity of the adjustment period. Within four weeks, most people can comfortably take 500 mg three times daily.

The berberine phytosome form achieves clinical effects at lower doses (200-400 mg daily) due to approximately five times better bioavailability than HCl. It's more expensive but produces less GI upset and requires fewer doses. Dihydroberberine (DHB) is another emerging higher-absorption form, though it has less clinical data than HCl.

Side effects and drug interactions

Bergamot

Bergamot extract is well-tolerated in all completed clinical trials lasting up to six months. Mild GI effects occur in some users at higher doses. No serious adverse events have been documented at studied doses.

The important interaction is with statins. Bergamottin, a furanocoumarin component in bergamot peel and essential oil, inhibits CYP3A4, the same enzyme responsible for the grapefruit-statin interaction. Well-standardized juice extracts (like Bergamonte) contain minimal bergamottin, significantly reducing this risk compared to bergamot essential oil or less standardized products. If you're on CYP3A4-metabolized statins (atorvastatin, lovastatin, simvastatin), discuss bergamot supplementation with your prescribing physician and use a standardized juice extract specifically.

Bergamot also theoretically affects other CYP3A4-metabolized drugs: calcium channel blockers, certain immunosuppressants, some benzodiazepines. These interactions are much weaker with standardized juice extract than with bergamot oil, but worth knowing if you're on multiple medications.

Avoid bergamot during pregnancy. The data simply doesn't exist to confirm safety, which is reason enough to pause.

Berberine

Berberine's most common side effect is GI disturbance, affecting roughly 10-35% of users in clinical trials. Diarrhea, constipation, bloating, and cramping are the typical complaints, most pronounced in the first two weeks and with higher doses. Starting low and titrating up, and always taking it with food, reduces this substantially. The phytosome form has meaningfully better GI tolerability.

The serious interactions are important to know.

Cyclosporine and tacrolimus: Berberine inhibits CYP3A4 and P-glycoprotein, raising blood levels of these immunosuppressants by up to 88% in documented studies. For organ transplant recipients, this is potentially dangerous. Avoid berberine with these drugs without specialist oversight.

Warfarin: Berberine inhibits CYP2C9, the primary enzyme that metabolizes warfarin. INR changes are documented when berberine is started or stopped. Regular INR monitoring is required if combining.

Diabetes medications: Additive blood sugar lowering with metformin, insulin, or sulfonylureas can cause hypoglycemia. Dose adjustment and monitoring are needed.

Pregnancy: Berberine is contraindicated. It crosses the placenta, may cause neonatal jaundice, and may stimulate uterine contractions. This isn't a theoretical concern. It's an absolute contraindication.

Choosing the right form

For bergamot

Bergamonte is the branded extract to look for. It's used in the majority of published clinical trials, standardized to 38% polyphenols, and manufactured to pharmaceutical-grade standards in Italy. If a product doesn't specify Bergamonte or show a polyphenol percentage on the label, you don't know what you're actually getting.

Bergamot phytosome is available and has clinical data supporting improved visceral fat reduction and lipid effects at lower doses. If GI tolerance is a concern or you prefer fewer capsules, the phytosome form is reasonable.

Avoid products that list "bergamot extract" without standardization information, or anything labeled as bergamot essential oil for metabolic purposes. It's a different product entirely.

For berberine

Berberine HCl is the most studied, most affordable form. It requires higher doses (1,500 mg daily) to produce consistent clinical effects, divided across meals. It's the form used in the metformin comparison trials and the majority of the blood sugar literature.

Berberine phytosome offers five times better bioavailability, requiring 200-400 mg daily to match the clinical effects of 1,500 mg HCl. Better GI tolerability is its primary advantage. If standard HCl causes ongoing GI issues after the initial adjustment period, phytosome is worth the price premium.

Pure encapsulations berberine and similar pharmaceutical-grade berberine HCl products are solid choices when you want clean labeling and third-party testing.

If you want to check how berberine fits with your full supplement stack before starting, our supplement interaction checker covers major interactions with common supplements and medications.

Tracking your results

You can't feel AMPK activation. You can't feel HMG-CoA reductase inhibition. You need biomarkers to evaluate whether either compound is actually working.

For bergamot, a lipid panel is the primary marker. Retest after 60-90 days of consistent use. Total cholesterol, LDL, HDL, and triglycerides are the standard panel. If you can access an advanced lipid panel that includes ApoB or sdLDL particle size, those markers are where bergamot's differentiated benefit shows up most clearly. Inflammation markers like hs-CRP are secondary targets worth tracking if you have baseline values.

For berberine, fasting glucose and fasting insulin give the fastest feedback, often showing changes within 2-4 weeks. HbA1c is the three-month average and needs at least 90 days before retesting. HOMA-IR (calculated from fasting glucose and insulin) is a sensitive insulin resistance marker. Liver enzymes (ALT, AST) are worth tracking if NAFLD is a concern.

The biological age calculator incorporates several metabolic markers if you want to track your broader biological age trajectory alongside specific biomarkers. Getting a baseline before starting either supplement and retesting after 90 days is the right approach.

Frequently asked questions

Is bergamot or berberine better for cholesterol?

Bergamot produces larger LDL reductions (20-40%) compared to berberine (10-18% average). Bergamot also specifically reduces small dense LDL particles, the most atherogenic fraction, and has data showing carotid plaque reduction over six months. For people whose primary concern is elevated LDL and cardiovascular risk, bergamot is the more targeted choice. That said, berberine meaningfully lowers LDL too, especially through PCSK9 inhibition, and is a valid option for people managing both blood sugar and cholesterol.

Is berberine better than bergamot for blood sugar?

Yes, significantly. Berberine has been directly compared to metformin in clinical trials and produces comparable HbA1c reductions. Meta-analyses show it lowers fasting blood glucose by approximately 20 mg/dL on average. Bergamot has some blood sugar effects (10-22% fasting glucose reduction in some trials), but this is a secondary effect. For prediabetes, insulin resistance, or type 2 diabetes, berberine is the compound to build around.

Can I take bergamot and berberine together?

Yes, and for metabolic syndrome the combination is rational. They hit different targets in lipid metabolism: bergamot blocks synthesis, berberine improves clearance via PCSK9 inhibition. Clinical studies on the combination have found 37% LDL reductions and over 50% triglyceride reductions alongside a Mediterranean diet. No known pharmacokinetic interactions exist between bergamot polyphenols and berberine. Practical starting doses: 500 mg bergamot once daily, 500 mg berberine two to three times daily with meals. Use the supplement interaction checker to confirm the combination works with any medications you're taking.

What is the best dose of bergamot extract?

500 mg per day of standardized extract (38% polyphenols) is the minimum effective dose established in clinical trials, and it's sufficient for most people. Higher doses up to 1,000 mg per day produce somewhat greater HDL improvements. Look specifically for "Bergamonte" branded extract or any extract standardized to at least 38% total polyphenols. Generic bergamot products without standardization information don't have confirmed clinical equivalence.

How long does bergamot take to lower cholesterol?

Significant lipid improvements appear within 30 days at 500-1,000 mg per day. The Mollace 2011 trial showed 24% LDL reduction after 30 days of consistent use. Carotid plaque reduction in the Toth 2015 study occurred over six months. Retest your lipid panel after 60-90 days to evaluate your response.

Does berberine lower cholesterol as effectively as statins?

Berberine produces LDL reductions of roughly 10-18% on average, compared to 20-55% for common statins depending on dose and type. It's less potent than mid-to-high-dose statins for LDL reduction specifically. However, berberine also lowers triglycerides substantially, improves blood sugar and insulin resistance, and supports gut microbiome health in ways statins don't. For people with modest cholesterol elevation who also have metabolic syndrome, berberine's broader metabolic effects may be more valuable than a statin's more targeted LDL effect.

Is bergamot safe with statins?

With caution. Well-standardized bergamot juice extract (Bergamonte) contains minimal furanocoumarin content, significantly reducing the CYP3A4 interaction risk compared to bergamot essential oil. But additive cholesterol lowering when combining bergamot with a statin is possible and can be significant. Discuss with your physician before combining. Pravastatin and rosuvastatin are not metabolized by CYP3A4 and have lower interaction risk than atorvastatin, lovastatin, or simvastatin.

Can I take berberine if I'm not diabetic?

Yes. The strongest evidence for berberine is in people with insulin resistance, prediabetes, or type 2 diabetes, but berberine also has evidence for metabolic syndrome, NAFLD, and lipid improvement in people without a diabetes diagnosis. The longevity argument for berberine centers on AMPK activation, which is relevant to general metabolic health and aging even in people with normal glucose. Start at a lower dose, monitor your blood sugar response for the first few weeks, and check interactions with any current medications.

What's the difference between bergamot and berberine vs metformin?

Metformin works primarily through AMPK activation and shares berberine's core mechanism. Berberine matches metformin's glycemic effects in direct comparison trials. Bergamot works differently, primarily through HMG-CoA reductase inhibition, more analogous to a statin than metformin. If you're on metformin and considering natural alternatives, berberine is the pharmacologically closer compound. If you're considering statin alternatives, bergamot is the closer analog. The berberine dosage for anti-aging discussion and its overlap with metformin is a popular topic in longevity circles.

Related guides

• Best berberine supplement: how to choose the right brand
• Berberine complex: what extra ingredients actually do
• Berberine phytosome supplements: the absorption upgrade explained
• Supplement interaction checker
• Biological age calculator

Sources

• Clinical application of bergamot for reducing cholesterol and cardiovascular disease markers: PMC6497409
• Bergamot reduces plasma lipids, atherogenic small dense LDL, and subclinical atherosclerosis: PMC4702027
• Efficacy of berberine in patients with type 2 diabetes mellitus: PubMed 18442638

---

The question isn't really bergamot or berberine. It's what your actual metabolic problem is. Elevated LDL with normal blood sugar? Start with bergamot. Insulin resistance and creeping HbA1c? Start with berberine. Metabolic syndrome with both? The combination is where the evidence gets particularly compelling. Use the free tools on WinAging to get your baselines before starting, then retest at 90 days. The data will tell you whether it's working.